Palliative treatment in dextro-transposition of the great arteries

Jump to navigation Jump to search

Dextro-transposition of the great arteries Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating dextro-transposition of the great arteries from other Diseases

Epidemiology and Demographics

Screening

Pre-natal dextro-transposition of the great arteries
Post-natal dextro-transposition of the great arteries
Infants with dextro-transposition of the great arteries

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

Cardiac catheterization

Electrophysiology Testing

Treatment

Palliative treatment

Corrective surgery

Follow up

ACC/AHA recommendations for reproduction

Case Studies

Case #1

Palliative treatment in dextro-transposition of the great arteries On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Palliative treatment in dextro-transposition of the great arteries

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Palliative treatment in dextro-transposition of the great arteries

CDC on Palliative treatment in dextro-transposition of the great arteries

Palliative treatment in dextro-transposition of the great arteries in the news

Blogs on Palliative treatment in dextro-transposition of the great arteries

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Palliative treatment in dextro-transposition of the great arteries

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

Palliative treatment

Critically ill newborns benefit from the infusion of Prostaglanding E1, which is used to prevent closure of the PDA (additional shunt) through which the systemic circulation is provided with a higher level of oxygen.

Balloon atrial septostomy, enlargement of the interatrial communication using a balloon, allowing better atrial-level mixing between the two parallel circulations. The catheter is introduced via femoral venous or umbilical venous approach, and passed into the right atrium, across the oval foramen and into the left atrium (LA) under echocardiographic or angiographic guidance. Once the ballon is in the LA, is inflated and drawned back across the oval foramen, producing a tear of the interatrial septum.

Antibiotics are often used because the patient is invaded with arterial and vein lines, nasogastric tube, urethral catheter, etc, that makes the patient very susceptible to infections.

Diuretics aid in flushing excess fluid from the body, thereby easing strain on the heart.

Cardiac glycosides, used to maintain proper heart rhythm while increasing the strength of each contraction.

Sedatives may be used palliatively to prevent a young child from pulling out any of their lines.

References